Global Antibiotics Market (2020 to 2026) – by Action Mechanism, Drug Class and Region – ResearchAndMarkets.com

Global Antibiotics Market (2020 to 2026) – by Action Mechanism, Drug Class and Region – ResearchAndMarkets.com




Global Antibiotics Market (2020 to 2026) – by Action Mechanism, Drug Class and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 – 2026” report has been added to ResearchAndMarkets.com’s offering.

The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.

Antibiotic is a substance that fights against bacterial and protozoan infections. Additionally, they help in treating many diseases like urinary tract infections, pneumonia, strep throat, skin infections, sinus infections, ear infections and many more. Antibiotics can be classified on various bases but the most common classification is done on the basis of spectrum of activity, chemical structures, and mode of action. Presently, the demand for beta-lactam and beta-lactamase inhibitors class of antibiotics is more among healthcare providers.

The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases. Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market. On the other hand, advanced prospect molecules and the development of novel combination therapies to cure antibiotic-resistant microbial infections are estimated to propel the market and provide great opportunities for the market players.

The increased cases of infectious diseases in developing regions like the Asia Pacific and the Middle East are estimated to support the market growth. According to the data provided by WHO, above 15% of the children’s death is caused by pneumonia. Similarly, tuberculosis is more prevalent in the South Asian and Sub-Saharan regions. Presently, the much-needed antibiotic treatment is accessible only to one-third of the infected population that further expands the disease burden.

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

Unique Offerings from the Publisher

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market composition and Scenario

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. Competition Analysis – Global

3.1 Cardinal Matrix

3.2 Recent Industry Wide Strategic Developments

3.2.1 Partnerships, Collaborations and Agreements

3.2.2 Product Launches and Product Expansions

3.2.3 Approvals

3.2.4 Acquisition and Mergers

3.3 Top Winning Strategies

3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)

3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players

Chapter 4. Global Antibiotics Market by Action Mechanism

4.1 Global Cell Wall Synthesis Inhibitors Market by Region

4.2 Global Protein Synthesis Inhibitors Market by Region

4.3 Global DNA Synthesis Inhibitors Market by Region

4.4 Global RNA Synthesis Inhibitors Market by Region

4.5 Global Mycolic Acid Inhibitors Market by Region

Chapter 5. Global Antibiotics Market by Drug Class

5.1 Global Cephalosporin Market by Region

5.2 Global Penicillin Market by Region

5.3 Global Fluoroquinolone Market by Region

5.4 Global Macrolides Market by Region

5.5 Global Carbapenem Market by Region

5.6 Global Aminoglycosides Market by Region

5.7 Global Sulfonamides Market by Region

5.8 Global Others Market by Region

Chapter 6. Global Antibiotics Market by Region

6.1 North America Antibiotics Market

6.2 Europe Antibiotics Market

6.3 Asia Pacific Antibiotics Market

6.4 LAMEA Antibiotics Market

Chapter 7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/tkzijr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900